Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345. [Phase 1]

View source ↗

Summary

A Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of GSK2339345 in subjects with cough has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• GSK2339345

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cough | Phase 1 | Status: COMPLETED